Adaptive sample size modification in clinical trials: start small then ask for more?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Statistics in Medicine

• Publication date

  2015-12-20

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1002/sim.6575PMID 26172385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Spot Sign and Tranexamic Acid on Preventing ICH Growth – AUStralasia Trial (STOP-AUST): Protocol of a Phase II Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial

  2014cited by this paper
• Unblinded Adaptive Statistical Information Design Based on Clinical Endpoint or Biomarker

  2013cited by this paper
• Group sequential tests for delayed responses (with discussion)

  2013influential reference
• Comments on ‘Adaptive increase in sample size when interim results are promising: A practical guide with examples’ by C. R. Mehta and S. J. Pocock

  2012cited by this paper
• Adaptive increase in sample size when interim results are promising: A practical guide with examples

  2011influential reference
• Comments on ‘Adaptive increase in sample size when interim results are promising: A practical guide with examples’

  2011cited by this paper
• Optimal two-stage group-sequential designs

  2008cited by this paper
• Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials

  2008cited by this paper
• Strategies for Including Patients Recruited During Interim Analysis of Clinical Trials

  2007cited by this paper
• Adaptive two‐stage designs in phase II clinical trials

  2006cited by this paper
• Are Flexible Designs Sound?

  2006cited by this paper
• Adaptive and nonadaptive group sequential tests

  2006influential reference
• Efficient group sequential designs when there are several effect sizes under consideration

  2006cited by this paper
• Standard versus adaptive monitoring procedures: a commentary

  2006cited by this paper
• Increasing the sample size when the unblinded interim result is promising

  2004influential reference
• On the inefficiency of the adaptive design for monitoring clinical trials

  2003influential reference
• Mid‐course sample size modification in clinical trials based on the observed treatment effect

  2002influential reference
• Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches

  2001cited by this paper
• Group Sequential Methods with Applications to Clinical Trials

  2001cited by this paper
• Modification of Sample Size in Group Sequential Clinical Trials

  1999cited by this paper
• Self-designing clinical trials.

  1998cited by this paper
• Designed extension of studies based on conditional power.

  1995cited by this paper
• Evaluation of experiments with adaptive interim analyses.

  1994influential reference
• Statistical Methods for Research Workers (Seventh Edition).

  1939cited by this paper
• Statistical methods for research workers. 5th edition

  1935cited by this paper
• Statistical methods for research workers

  1927cited by this paper

• Benefits of group sequential design and sample size re-estimation for randomised controlled trials evaluating the prevention of ventilator-associated pneumonia: a simulation study informed by real world data

  2025cites this paper
• Optimal and Efficient Sample Size Re-estimation: A Dynamic Cost Framework

  2025influential citation
• Adaptive clinical trial design with delayed treatment effects using elicited prior distributions

  2025cites this paper
• Adaptive promising zone design for sequential parallel comparison design with continuous outcomes

  2025cites this paper
• Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials

  2025cites this paper
• Adaptive sample size re-estimation designs for a two-stage randomized trial with binary outcome

  2025cites this paper
• Power priors and type I error control: constrained borrowing of external control data.

  2025cites this paper
• Design and monitoring of clinical trials with an interim analysis and a negative binomial endpoint.

  2024cites this paper
• Two-stage group-sequential designs with delayed responses – what is the point of applying corresponding methods?

  2024cites this paper
• Sample size recalculation in three-stage clinical trials and its evaluation

  2024influential citation
• Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints

  2024influential citation
• Eliciting the Discount Parameter in a Power Prior Method on the Basis of the Type I Error Consideration

  2024cites this paper
• A systematic approach to adaptive sequential design for clinical trials: using simulations to select a design with desired operating characteristics

  2024cites this paper
• New results on optimal conditional error functions for adaptive two-stage designs

  2024cites this paper
• A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart

  2024influential citation
• Point estimation, confidence intervals, and P‐values for optimal adaptive two‐stage designs with normal endpoints

  2024cites this paper
• An introduction to group sequential methods: planning and multi-aspect optimization

  2023cites this paper
• Power Considerations in Designing and Interpreting Adaptive Clinical Trials.

  2023cites this paper
• Promising zone two-stage design for a single-arm study with binary outcome

  2023cites this paper
• Optimal adaptive promising zone designs

  2022cites this paper
• Optimization of adaptive designs with respect to a performance score

  2022cites this paper
• An Optimal Hybrid Approach to Calculate Conditional Power

  2022cites this paper
• Optimal unplanned design modification in adaptive two‐stage trials

  2022cites this paper
• Optimal planning of adaptive two‐stage designs

  2021cites this paper
• The adoptr Package: Adaptive Optimal Designs for Clinical Trials in R

  2021cites this paper
• Interim Monitoring and Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials

  2021cites this paper
• Designing Confirmatory Trials with Desired Characteristics

  2021cites this paper
• The Adaptive designs CONSORT Extension (ACE) Statement: A checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

  2021cites this paper
• Improving sample size recalculation in adaptive clinical trials by resampling

  2021cites this paper
• A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation

  2020influential citation
• Comments on “Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects” by Jose Jimenez, Viktoriya Stalbovskaya, and Byron Jones. Pharm Stat. 18:287‐303, 2019, DOI: 10.1002/pst.1923

  2020cites this paper
• Evaluation of an Adaptive Seamless Design for a Phase II/III Clinical Trial in Recurrent Events Data to Demonstrate Reduction in Number of Acute Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD)

  2020cites this paper
• Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials

  2020cites this paper
• A Note on the Promising Zone Approach in Adaptive Trial Design

  2020cites this paper
• A note on the shape of sample size functions of optimal adaptive two-stage designs

  2020cites this paper
• Sample size re-estimation for pivotal clinical trials.

  2020cites this paper
• A systematic review of the “promising zone” design

  2020cites this paper
• Interim analysis incorporating short‐ and long‐term binary endpoints

  2019cites this paper
• A Critical Review on Adaptive Sample Size Re-estimation (SSR) Designs for Superiority Trials with Continuous Endpoints

  2019cites this paper
• The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

  2019cites this paper
• Comments on “Adaptive sample size modification in clinical trials: Start small then ask for more?”

  2019cites this paper
• Authors' reply

  2019cites this paper
• Monitoring model for predicting maize grain moisture at the filling stage using NIRS and a small sample size

  2019cites this paper
• A variational approach to optimal two‐stage designs

  2019cites this paper
• Bayesian sample size determination for a Phase III clinical trial with diluted treatment effect

  2018cites this paper
• Adaptive designs in clinical trials: why use them, and how to run and report them

  2018cites this paper
• Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-assessment

  2018cites this paper
• Innovative adaptive designs in oncology clinical trials with drug combinations

  2018influential citation
• Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects

  2018cites this paper
• Optimal promising zone designs

  2018cites this paper
• Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies

  2017cites this paper
• Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-assessment

  2017influential citation
• Sample size re-estimation and other midcourse adjustments with sequential parallel comparison design

  2017influential citation
• The Utility of Adaptive Designs in Publicly Funded Confirmatory Trials

  2016cites this paper
• Authors' response to comments

  2016influential citation
• Decision Tools for Adaptive Designs

  2016cites this paper
• Adaptive Seamless Design for Establishing Pharmacokinetic and Efficacy Equivalence in Developing Biosimilars

  2016cites this paper